0914 GMT - CVS Group's disposal of its crematorium division helps simplify the company's structure and sheds a business unit that provides a minor contribution to earnings, Davy Research analyst Colin Grant says. The analyst adds in a research note that the division can be considered non-core. "Overall, we view this disposal as opportunistic and attractive," Grant says. At a sale price of 42.4 million pounds, the disposal underscores the undervaluation of the rest of the company, the analyst says. The company expects to post a one-off 32.0 million pounds gain in its year-end account from the sale. CVS Group's shares trade 2.4% higher at 1,030 pence. (pierre.bertrand@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 05:14 ET (09:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.